Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity
Currently, no medications are approved for obesity treatment in children younger than 12 years, but a randomized controlled trial of 82 patients 6 to 12 years of age found that liraglutide resulted in an estimated BMI reduction of 7% compared with placebo, suggesting potential future applications
Contact us on WhatsApp for a free consultation at Sant Clinics Barcelona, Avenida Diagonal 384.
It also keeps nerves healthy and aids in DNA creation
2021 Feb;19(2):219-231.e1
BMJ (2017) 359:j4849
US$ 28.67
US$ 25.23
US$ 25.78
